Boosters: the immunological equivalent of heroin addiction – expert research bioscientist Dr David Wiseman

Loading player...
Though the uptake of COVID-19 boosters remains low in South Africa, with a mere 3.6 million booster shots reportedly administered by August, the South African Government and international health authorities continue to urge citizens to join the conga line of “responsible” people queuing to get boosted. Given the significantly high seroprevalence of SARS-CoV-2 antibodies among the South African population, there is no justification for boosters, even less the FDA’s Emergency Use Authorisation thereof. In this long-form interview with Dr David Wiseman, a PhD research bioscientist with a background in pharmacy, pharmacology and immunology, the significant risks associated with continued boosting were meticulously examined. Wiseman’s ability to simplify technical knowledge and his explanation of the dangers associated with boosters were second to none. According to Wiseman, attempting to boost our way out of the pandemic is the immunological equivalent of heroin addiction. Wiseman furthermore provided critical insight into the FDA and CDC’s egregious abandonment of once well-established standards, evidenced by the EUA issued for the new untested BA4/5 bivalent boosters. Note that Wiseman referred to several slides during the interview which have been embedded in the article on BizNews.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Nov 2022 1AM English South Africa Investing · Business News

Other recent episodes

BizNews Edge: Why the IRR's John Endres is more bullish on SA than Britain

John Endres, CEO of the Institute for Race Relations, tells BizNews that the elite consensus defending BEE is cracking, even as its beneficiaries defend it loudest. He points to the Starlink saga - blocked partly over empowerment shareholding while a pricier, slower rival wins state favour - as proof the…
13 Jul 8AM 24 min

A world-first: the bond that pays out when nature wins

In this BizNews interview, Irakli Rekhviashvili sits down with the three people behind FirstRand's R2.5 billion Cape Water Performance-Based Bond, the first time a commercial bank anywhere in the world has tied a bond's payout to nature. The Nature Conservancy's Louise Stafford traces it to 2018, when Cape Town's dams…
12 Jul 8AM 15 min

SA rugby's ticket strategy prices Bok fans out of stadiums

Springbok ticket prices have soared, suites have been taken over under “clean stadium” rules, and loyal supporters are being squeezed out. BizNews Rugby's boots-on-the-ground reporter, Rory Steyn, speaks to representatives from legendary Joburg rugby clubs and bitter rivals Pirates and Wanderers, as well as chartered accountant and former Sun International…
11 Jul 10AM 30 min